Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8963627 | Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology | 2018 | 4 Pages |
Abstract
It is well known that osteonecrosis of the jaw is induced by the adverse effect of medication including bisphosphonates and anti-receptor activator of nuclear factor-kappa B ligand antibody. Recently, a few case reports showed that methotrexate is capable of inducing osteonecrosis of the jaw in the absence of antiresorptive or antiangiogenic agents. We herein introduce a case of osteonecrosis of the jaw with pancytopenia by low-dose methotrexate administration for rheumatoid arthritis. The patient of this case has been extracted teeth and subsequently suffered from the pain osteonecrosis of the jaw. Referring to our hospital, the patient was diagnosed as disseminated intravascular coagulation. Being received appropriate treatment, his condition was gradually recovered and he was discharged at thirty days after admission. We should bear this case in mind in examining patients being prescribed methotrexate.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Tsuyoshi Sato, Masahiko Okubo, Naoki Hayashi, Megumi Yumoto, Yosuke Fukushima, Tetsuya Yoda,